VENTURE CAPITAL AND FINANCING INNOVATION

Assessment of Fred Khosravi 's career and record as a medical device entrepreneur

Fred has gradually built a reputable name for himself as a medical device entrepreneur . In to do this , he has been found to deliver on the major requirements that venture capitalists and private investors look for before they invest

These can be seen below

He has repeatedly delivered cutting edge , best-in-class commercial medical devices that have been able to capture a sizeable part of the market

He has successfully founded seven start-up companies in this field

because of his understanding of providing value propositions and of raising money to support these ventures

Two years after Boston Scientific bought Fred Khosravi 's fifth start up (EPI , the EPI filter generated 65 million in revenue and captured an impressive 70 market share

AccessClosure 's Matrix was expected to capture 20 of the closure market and Finale , 50-60 within ten years of launch

He has been able to deliver increasingly attractive returns to shareholders of his firms

He started with Focal , which overall earned investors a nominal return on their investment . By the time his fifth company Embolic Protection Inc (EPI ) was sold to Boston Scientific , investors of series-A shares got over 18 times return on their investment

He has also been able to establish a good rapport with the VC community thereby making it easy to get funding for his projects

Initially , Fred Khosravi had been wary of the Venture Capital community However , he had gradually built a name in that community , starting with Mark Levin , partner Mayfield Fund , in his first start up , Focal Therapeutics . Levin ended up also playing a mentoring role to Fred

At Endotex , his second startup , he conceded the CEO role to someone else because he felt that he would bring the required discipline to the company . This showed a commitment to the success of the company . At this time , investors even stuck around while the company was going through some hurdles

Later on , he secured repeated investment from ONSET Ventures and got funding from other VCs and private investors

He has formed good relationships with other entrepreneurs and with co-workers thereby giving him credibility during the due diligence process that venture capitalists go through before they offer funding

He developed a strong relationship with co-founder (Prof . Ulrich Sigwart ) during the setup of Endotex , when he helped Sigwart negotiate the terms of the licensing agreement

Khosravi had a lot of credibility with senior management at Boston Scientific

He has formed good relationships licensing authorities

Khosravi 's good rapport with the FDA is a great plus for him as an entrepreneur . Regulatory bodies are a serious threat to companies and can restrict entry into the industry

He has been able to show that he is transparent and this has made him trustworthy and has sped up his requests for licensing from the authority

2 . Rules or generalizations about medical device startups based on Khosravi 's experiences

Based on Khosravi 's experiences I can derive...